Japan's Astellas Pharma inks oncology deal worth $800 M with US-based biotech startup Kelonia
Therapeutics | News | 0 Comment
Japan headquartered Astellas Pharma and US-based biotech startup Kelonia Therapeutics have announced a collaborative eff...Read more
Japan's Astellas Pharma announces strategic collaboration with US-based Mass General Brigham
Cell & Gene | News | 0 Comment
Japan-based Astellas Pharma Inc. has entered into a strategic collaboration with US-based Mass General Brigham ...Read more
Japan's Astellas Pharma buys US-based startup Propella Therapeutics for $175 M
BioTech | News | 0 Comment
Japan-based Astellas Pharma and US-based startup Propella Therapeutics have entered into a merger agreement pursuant to ...Read more
Japan's Astellas Pharma & University of Tsukuba partner to create new drug discovery startups
Drug Discovery | News | 0 Comment
Japan-based University of Tsukuba and Astellas Pharma have signed a letter of confirmation regarding a strateg...Read more
Japanese pharma firm Astellas to invest more than €330 M in Ireland facility
Pharma | News | 0 Comment
Japan headquartered Astellas Pharma has announced its intention to submit a planning application to build a new state-of...Read more
Taiwan | News | 0 Comment
Menarini Asia-Pacific has entered into a long-term exclusive licensing partnership with Japanese firm Astellas Pharma fo...Read more
Japan's Astellas Pharma invests $50 M for redefining cancer cell therapy
BioTech | News | 0 Comment
Japanese firm Astellas Pharma Inc. and US-based startup Poseida Therapeutics, Inc. have announced a strategic investment...Read more
US-based startup Cullgen inks billion-dollar deal with Japanese pharma firm Astellas
Pharma | News | 0 Comment
Japan-headquartered Astellas Pharma and US-based startup Cullgen have entered into a research collaboration and exclusiv...Read more
Japan's Astellas Pharma enters into cancer research collaboration with Sony Corporation
Japan | News | 0 Comment
Japan headquartered Sony Corporation and Astellas Pharma Inc. have entered into a collaborative research agree...Read more
Japan's Astellas Pharma acquires US-based Iveric Bio for $5.9 B
Japan | News | 0 Comment
Japan headquartered Astellas Pharma Inc. and US-based Iveric Bio have entered into a definitive agreement under which As...Read more